You cannot add another "Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer" to your cart. View cart

Article: COVID-19 vaccination in immunocompromised patients with haematologic diseases

€3.03

SKU: product-article-42236 Category: General

Description
Reviews (0)

Description

COVID-19 vaccination in immunocompromised patients with haematologic diseases

Reviews

There are no reviews yet.

Be the first to review “Article: COVID-19 vaccination in immunocompromised patients with haematologic diseases”

You must be logged in to post a review.

Top

Article: COVID-19 vaccination in immunocompromised patients with haematologic diseases

Description

Reviews

Related products

Article: Highlights in respiratory oncology

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Highlights in melanoma

Article: Calendar of events